Literature DB >> 17301282

Distribution study of Chlamydia trachomatis serovars among high-risk women in China performed using PCR-restriction fragment length polymorphism genotyping.

Xing Gao1, Xiang-Sheng Chen, Yue-Ping Yin, Ming-Ying Zhong, Mei-Qin Shi, Wan-Hui Wei, Qiang Chen, Rosanna W Peeling, David Mabey.   

Abstract

This was one of the first epidemiological studies in China focused on genital Chlamydia trachomatis serotype distribution in high-risk female populations using omp1 gene-based restriction fragment length polymorphism analysis. One thousand seven hundred seventy cervical swab samples from women attending sexually transmitted disease clinics and female sex workers in six cities in China (Shenzhen and Guangzhou in southern China, Nanjing and Shanghai in eastern China, and Nanning and Chengdu in southwestern China) were subjected to serovar genotyping. The proportion of omp1 genes successfully amplified in 240 C. trachomatis plasmid-positive samples was 94.2% (226/240). Serotypes E (n = 63; 27.9%), F (n = 53; 23.5%), G (n = 28; 12.4%), and D (n = 25; 11.1%) were most prevalent. Though there was no significant difference in the geographic distribution of C. trachomatis, serotype E was predominant in the South (32.1%) and East (27.1%), while serotype F was predominant in the Southwest (28.3%). Serotype F infection was associated with young age and single status. Serovar G was associated with lower abdominal pain; 47.5% of asymptomatic patients were infected with serovar E. These results provide information on distribution of genital C. trachomatis serotypes among high-risk women in China and indicate that high-risk women, including those who are asymptomatic, can be infected with multiple serovars of C. trachomatis, revealing exposure to multiple sources of infection. Although the scope for generalizations is limited by our small sample size, our results showing clinical correlations with genotypes are informative.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301282      PMCID: PMC1865819          DOI: 10.1128/JCM.02076-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Analysis of Chlamydia trachomatis serovars in endocervical specimens derived from pregnant Japanese women.

Authors:  M Ikehata; K Numazaki; S Chiba
Journal:  FEMS Immunol Med Microbiol       Date:  2000-01

2.  Genotyping of Chlamydia trachomatis would improve contact tracing.

Authors:  Lars Falk; Margret Lindberg; Margaretha Jurstrand; Anders Bäckman; Per Olcén; Hans Fredlund
Journal:  Sex Transm Dis       Date:  2003-03       Impact factor: 2.830

Review 3.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

4.  Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1).

Authors:  C I Bandea; K Kubota; T M Brown; P H Kilmarx; V Bhullar; S Yanpaisarn; P Chaisilwattana; W Siriwasin; C M Black
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

5.  Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden.

Authors:  M Jurstrand; L Falk; H Fredlund; M Lindberg; P Olcén; S Andersson; K Persson; J Albert; A Bäckman
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

6.  Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China.

Authors:  Y-P Yin; R W Peeling; X-S Chen; K-L Gong; H Zhou; W-M Gu; H-P Zheng; Z-S Wang; G Yong; W-L Cao; M-Q Shi; W-H Wei; X-Q Dai; X Gao; Q Chen; D Mabey
Journal:  Sex Transm Infect       Date:  2006-11-22       Impact factor: 3.519

7.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

8.  Combination of PCR targeting the VD2 of omp1 and reverse line blot analysis for typing of urogenital Chlamydia trachomatis serovars in cervical scrape specimens.

Authors:  Monica Molano; Chris J L M Meijer; Servaas A Morré; Rene Pol; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.

Authors:  Rutger F Nieuwenhuis; Jacobus M Ossewaarde; Hannelore M Götz; Jan Dees; H Bing Thio; Maarten G J Thomeer; Jan C den Hollander; Martino H A Neumann; Willem I van der Meijden
Journal:  Clin Infect Dis       Date:  2004-09-08       Impact factor: 9.079

10.  Evaluation of serotyping using monoclonal antibodies and PCR-RFLP for Chlamydia trachomatis serotype identification.

Authors:  T Y Choi; D A Kim; Y H Seo
Journal:  J Korean Med Sci       Date:  2001-02       Impact factor: 2.153

View more
  28 in total

Review 1.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

2.  Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Authors:  F O Eko; D N Okenu; U P Singh; Q He; C Black; J U Igietseme
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

Review 3.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden.

Authors:  T Lagergård; R Hadad; P Tunbäck; L Lindholm; G-B Löwhagen; M Unemo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-01       Impact factor: 3.267

5.  Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy.

Authors:  M Donati; A Di Francesco; A D'Antuono; S Pignanelli; A Shurdhi; A Moroni; R Baldelli; R Cevenini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-29       Impact factor: 3.267

6.  Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens.

Authors:  Koen Quint; Carolina Porras; Mahboobeh Safaeian; Paula González; Allan Hildesheim; Wim Quint; Leen-Jan van Doorn; Sandra Silva; Willem Melchers; Mark Schiffman; Ana Cecilia Rodríguez; Sholom Wacholder; Enrique Freer; Bernal Cortes; Rolando Herrero
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

7.  Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.

Authors:  Hervé C Gerard; Jessica A Stanich; Judith A Whittum-Hudson; H Ralph Schumacher; John D Carter; Alan P Hudson
Journal:  Microb Pathog       Date:  2009-11-18       Impact factor: 3.738

8.  Repeated Chlamydia trachomatis genital infections in adolescent women.

Authors:  Byron E Batteiger; Wanzhu Tu; Susan Ofner; Barbara Van Der Pol; Diane R Stothard; Donald P Orr; Barry P Katz; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

9.  Vaginal Gel Component Hydroxyethyl Cellulose Significantly Enhances the Infectivity of Chlamydia trachomatis Serovars D and E.

Authors:  Tímea Raffai; Katalin Burián; László Janovák; Anita Bogdanov; Johannes H Hegemann; Valéria Endrész; Dezső P Virok
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 10.  Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine.

Authors:  Seema Shetty; Christina Kouskouti; Uwe Schoen; Nikolaos Evangelatos; Shashidhar Vishwanath; Kapaettu Satyamoorthy; Franz Kainer; Angela Brand
Journal:  Braz J Microbiol       Date:  2021-06-23       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.